G

GemPharmatech Co Ltd
SSE:688046

Watchlist Manager
GemPharmatech Co Ltd
SSE:688046
Watchlist
Price: 13.53 CNY -1.24% Market Closed
Market Cap: 5.5B CNY
Have any thoughts about
GemPharmatech Co Ltd?
Write Note

GemPharmatech Co Ltd
Other Current Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

GemPharmatech Co Ltd
Other Current Liabilities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other Current Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
G
GemPharmatech Co Ltd
SSE:688046
Other Current Liabilities
ÂĄ134.2m
CAGR 3-Years
21%
CAGR 5-Years
37%
CAGR 10-Years
N/A
WuXi AppTec Co Ltd
SSE:603259
Other Current Liabilities
ÂĄ6.4B
CAGR 3-Years
3%
CAGR 5-Years
16%
CAGR 10-Years
N/A
Pharmaron Beijing Co Ltd
SZSE:300759
Other Current Liabilities
ÂĄ1.7B
CAGR 3-Years
8%
CAGR 5-Years
31%
CAGR 10-Years
N/A
WuXi Biologics (Cayman) Inc
HKEX:2269
Other Current Liabilities
ÂĄ4.5B
CAGR 3-Years
12%
CAGR 5-Years
36%
CAGR 10-Years
N/A
Hangzhou Tigermed Consulting Co Ltd
SZSE:300347
Other Current Liabilities
ÂĄ1.4B
CAGR 3-Years
20%
CAGR 5-Years
23%
CAGR 10-Years
35%
W
WuXi XDC Cayman Inc
HKEX:2268
Other Current Liabilities
ÂĄ582.8m
CAGR 3-Years
211%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

GemPharmatech Co Ltd
Glance View

Market Cap
5.5B CNY
Industry
Life Sciences Tools & Services

GemPharmatech Co., Ltd. engages in research and development, manufacture, and sale of experimental mouse models. The company is headquartered in Nanjing, Jiangsu and currently employs 1,342 full-time employees. The company went IPO on 2022-04-25. The firm uses gene-editing and other technologies to produce mouse models. The firm also involves in the business of customized model breeding, drug efficacy analysis, and model customization. The Company’s products are mainly used to satisfy the experimental demands in the fields of gene function cognition, disease mechanisms analysis, drug target discovery, and other fundamental researches.

Intrinsic Value
21.04 CNY
Undervaluation 36%
Intrinsic Value
Price
G

See Also

What is GemPharmatech Co Ltd's Other Current Liabilities?
Other Current Liabilities
134.2m CNY

Based on the financial report for Dec 31, 2023, GemPharmatech Co Ltd's Other Current Liabilities amounts to 134.2m CNY.

What is GemPharmatech Co Ltd's Other Current Liabilities growth rate?
Other Current Liabilities CAGR 5Y
37%

Over the last year, the Other Current Liabilities growth was 28%. The average annual Other Current Liabilities growth rates for GemPharmatech Co Ltd have been 21% over the past three years , 37% over the past five years .

Back to Top